We are live on ! Find out more
KWMG

King Wealth Management Group Portfolio holdings

AUM $914M
1-Year Est. Return 24.3%
This Fund
S&P 500
This Quarter Est. Return
+5.77%
1 Year Est. Return
+24.3%
3 Year Est. Return
+85.96%
5 Year Est. Return
+105%
10 Year Est. Return
+377.86%
AUM
$642M
AUM Growth
+$41.9M
Cap. Flow
+$9.64M
Cap. Flow %
1.5%
Top 10 Hldgs %
55.92%
Holding
157
New
13
Increased
36
Reduced
77
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 17.42%
2 Healthcare 9.19%
3 Financials 7.76%
4 Consumer Staples 4.97%
5 Consumer Discretionary 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
151
Heron Therapeutics
HRTX
$63.5M
$46K 0.01%
23,299
+8,000
+52% +$19.1K
BAC icon
152
Bank of America
BAC
$448B
-5,226
Closed -$208K
DC icon
153
Dakota Gold
DC
$827M
-13,000
Closed -$33K
DG icon
154
Dollar General
DG
$26.9B
-6,988
Closed -$924K
F icon
155
Ford
F
$55.4B
-10,476
Closed -$131K
GD icon
156
General Dynamics
GD
$106B
-959
Closed -$278K
NVO
157
Novo Nordisk
NVO
$205B
-14,784
Closed -$2.11M

Similar funds

King Wealth Management Group's Q3 2024 Portfolio in Review

As of Q3 2024, King Wealth Management Group held 157 positions worth $642M, up 7% from $600M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

King Wealth Management Group's Q3 2024 filing shows 13 new, 36 increased, 77 reduced and 6 closed positions. Its largest new stake was Teva Pharmaceuticals: 98,102 shares worth $1.77M. The largest sale was Johnson & Johnson, an estimated $5.25M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • King Wealth Management Group's largest Q3 2024 buy was Teva Pharmaceuticals: 98,102 shares worth $1.77M.
  • King Wealth Management Group added most to Microsoft in Q3 2024, an estimated $12.5M increase.
  • King Wealth Management Group's biggest Q3 2024 reduction was Johnson & Johnson, cutting an estimated $5.25M.
  • King Wealth Management Group fully exited Novo Nordisk in Q3 2024, selling an estimated $2.11M.
  • King Wealth Management Group's ten largest holdings make up 56% of its $642M portfolio in Q3 2024.
  • King Wealth Management Group opened 13 new positions and closed 6 in Q3 2024.
  • King Wealth Management Group's portfolio value rose 7% quarter-over-quarter to $642M.

Based on King Wealth Management Group's 13F filing for Q3 2024, filed 6 Nov 2024.